51 results
Page 2 of 3
8-K
EX-99.1
vqlj8smp 6ro951
9 May 19
BioTime ReportS FIRST Quarter 2019 Financial Results AND PROVIDES
4:25pm
8-K
EX-99.1
nkd1 oswktrjb7
2 May 19
BIOTIME presentS UPDATED DATA FROM OPREGENĀ® PHASE i/IIA CLINICAL STUDY AT THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY ANNUAL MEETING
9:00am
8-K
EX-99.1
yvtx9 1vmvd
29 Apr 19
BIOTIME TO PRESENT SCiSTAR CLINICAL STUDY TOP-LINE DATA AT THE 26TH ANNUAL AMERICAN SOCIETY FOR NEURAL THERAPY AND REPAIR CONFERENCE
9:00am
8-K
EX-99.1
b8js7bfo8nfc 58m
14 Mar 19
BioTime ReportS FOURTH Quarter AND FULL YEAR 2018 Financial Results
4:37pm
424B5
96s3cdqga14ckyji
3 Oct 14
Prospectus supplement for primary offering
12:00am
424B5
o23ygzqwb
26 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
jtt9aug2fy1lo6 gvy
2 Aug 13
Prospectus supplement
12:00am
424B5
010i1rfx ib3l1e
3 Jun 13
Prospectus supplement for primary offering
12:00am